Literature DB >> 33065633

Transplant Oncology in Primary and Metastatic Liver Tumors: Principles, Evidence, and Opportunities.

Gonzalo Sapisochin1, Taizo Hibi2, Christian Toso3, Kwan Man4, Marina Berenguer5, Julie Heimbach6, Tim F Greten7, Trevor J Pugh8,9,10, Laura A Dawson11, Vincenzo Mazzaferro12.   

Abstract

Transplant oncology defines any application of transplant medicine and surgery aimed at improving cancer patients' survival and/or quality of life. In practice, liver transplantation for selected hepato-biliary cancers is the only solid organ transplant with demonstrated efficacy in curing cancer. Four are the proposed future contributions of transplant oncology in hepato-biliary cancer (4-e). (1) evolutionary approach to cancer care that includes liver transplantation; (2) elucidation of self and non-self recognition systems, by linking tumor and transplant immunology; (3) exploration of innovative endpoints both in clinical and experimental settings taking advantage from the access to the entire liver explant; (4) extension of surgical limitation in the multidisciplinary approach to hepato-biliary oncology. The aim of this review is to define the principles of transplant oncology that may be applied to hepato-biliary cancer treatment and research, attempting to balance current evidences with future opportunities.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33065633     DOI: 10.1097/SLA.0000000000004071

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Immunotherapy as a Neoadjuvant Therapy for a Patient with Hepatocellular Carcinoma in the Pretransplant Setting: A Case Report.

Authors:  Maen Abdelrahim; Abdullah Esmail; Godsfavour Umoru; Kiersten Westhart; Ala Abudayyeh; Ashish Saharia; Rafik M Ghobrial
Journal:  Curr Oncol       Date:  2022-06-15       Impact factor: 3.109

2.  Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation?

Authors:  Axel Andres; Gonzalo Sapisochin; Silvio Nadalin; René Adam; Christian Toso
Journal:  Transpl Int       Date:  2021-11       Impact factor: 3.842

3.  Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP-1/ROS Axis in T Cells.

Authors:  Sai Zhang; Shunli Fan; Zhenglu Wang; Wen Hou; Tao Liu; Sei Yoshida; Shuang Yang; Hong Zheng; Zhongyang Shen
Journal:  Oxid Med Cell Longev       Date:  2022-03-24       Impact factor: 6.543

Review 4.  Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature.

Authors:  Susumu Eguchi; Masaaki Hidaka; Takanobu Hara; Hajime Matsushima; Akihiko Soyama
Journal:  Ann Gastroenterol Surg       Date:  2022-03-23

Review 5.  Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.

Authors:  Qimeng Gao; Imran J Anwar; Nader Abraham; Andrew S Barbas
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.